Principal Investigators

    ORYZON GENOMICS, S.A.

    Institution

    ORYZON GENOMICS, S.A.

    Contact information of lead PI

    Country

    Spain

    Title of project or programme

    THERAPEUTIC USE OF EPIGENETIC MODULATORS IN ONCOLOGICAL AND NEURODEGENERATIVE DISEASE

    Source of funding information

    CDTI

    Total sum awarded (Euro)

    € 920,002

    Start date of award

    01/10/2015

    Total duration of award in years

    2.8

    The project/programme is most relevant to:

    Alzheimer's disease & other dementias

    Keywords

    Research Abstract

    Lay Summary

    Further information available at:

Types: Investments > €500k
Member States: Spain
Diseases: Alzheimer's disease & other dementias
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF